Cardiovascular Systems (CSII) Stock Price, News & Analysis

Cardiovascular Systems, Inc. (NASDAQ:CSII) announced its quarterly earnings data on Wednesday, February, 8th. The medical device company reported ($0.20) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by $0.05. The medical device company earned $61.45 million during the quarter, compared to analysts' expectations of $63.06 million. Cardiovascular Systems had a negative net margin of 15.79% and a negative trailing twelve-month return on equity of 15.39%. The company's revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.23) EPS.

35 employees have rated Cardiovascular Systems Chief Executive Officer Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among the company's employees. 83.0% of employees surveyed would recommend working at Cardiovascular Systems to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG).